Try it
Psychiatry · Psychopharmacology: valproate
Sample itemWhich pre-treatment issue is especially important before prescribing valproate to a person who could become pregnant?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Its major teratogenic risk
Valproate has substantial fetal risks, including neural tube defects and adverse neurodevelopmental outcomes, so prescribing requires careful risk assessment and counseling. Local regulatory pregnancy-prevention requirements must be followed.
Option by option
A. Risk of an acute hypertensive crisis with cheese
Tyramine reactions are associated with monoamine oxidase inhibitors.
B. Its major teratogenic risk (correct)
Correct. Teratogenicity is a central safety consideration for valproate.
C. Risk of irreversible deafness in all patients
Irreversible deafness is not its defining reproductive safety issue.
D. Mandatory neutrophil monitoring
Neutrophil monitoring is particularly associated with clozapine.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Psychiatry questions
- Psychopharmacology: valproateWhich counselling point is essential before prescribing valproate to a person who may be…
- PsychopharmacologyLithium use during the first trimester of pregnancy is associated with which congenital…
- Psychotic disordersWhich of the following is a Schneiderian first-rank symptom of schizophrenia?
- Organic psychiatryAn elderly patient on a surgical ward develops acute confusion that fluctuates through t…